Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China
· Delayed Price · Currency is CNY 27.77
+0.02 (0.07%)
May 13, 2025, 3:00 PM CST
Yifeng Pharmacy Chain Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 23,333 | 23,295 | 22,078 | 19,382 | 14,807 | 12,813 | Upgrade
|
| Other Revenue | 767.13 | 767.13 | 510.66 | 504.62 | 519 | 331.15 | Upgrade
|
| Revenue | 24,100 | 24,062 | 22,588 | 19,886 | 15,326 | 13,145 | Upgrade
|
| Revenue Growth (YoY) | 3.46% | 6.53% | 13.59% | 29.75% | 16.60% | 27.91% | Upgrade
|
| Cost of Revenue | 14,491 | 14,492 | 14,030 | 12,082 | 9,184 | 8,183 | Upgrade
|
| Gross Profit | 9,609 | 9,570 | 8,558 | 7,805 | 6,143 | 4,961 | Upgrade
|
| Selling, General & Admin | 7,249 | 7,262 | 6,450 | 5,782 | 4,717 | 3,705 | Upgrade
|
| Research & Development | 30.99 | 33.94 | 33.55 | 25.31 | 15.64 | 8.31 | Upgrade
|
| Other Operating Expenses | 49.96 | 52.63 | 57.59 | 59.1 | 28.18 | 49.95 | Upgrade
|
| Operating Expenses | 7,334 | 7,347 | 6,546 | 5,877 | 4,765 | 3,770 | Upgrade
|
| Operating Income | 2,275 | 2,224 | 2,012 | 1,928 | 1,377 | 1,191 | Upgrade
|
| Interest Expense | -231.69 | -221.37 | -160.53 | -165.21 | -168.99 | -186.08 | Upgrade
|
| Interest & Investment Income | 190.77 | 180.78 | 135.66 | 80.08 | 98.51 | 87.92 | Upgrade
|
| Other Non Operating Income (Expenses) | -25.61 | -25.18 | -18.94 | -12.81 | -10.03 | -13.94 | Upgrade
|
| EBT Excluding Unusual Items | 2,209 | 2,158 | 1,969 | 1,830 | 1,297 | 1,079 | Upgrade
|
| Impairment of Goodwill | -18.83 | -18.83 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 59.92 | 49.94 | 41.82 | 23.17 | 6.85 | 0.32 | Upgrade
|
| Asset Writedown | -8.05 | -3.84 | -12.73 | -10.33 | -1.43 | -1.58 | Upgrade
|
| Other Unusual Items | -4.62 | -2.66 | 39.87 | 34.99 | 35.49 | 49.39 | Upgrade
|
| Pretax Income | 2,237 | 2,182 | 2,038 | 1,877 | 1,338 | 1,127 | Upgrade
|
| Income Tax Expense | 536.66 | 529.67 | 456.66 | 454.06 | 347.16 | 287.92 | Upgrade
|
| Earnings From Continuing Operations | 1,700 | 1,653 | 1,581 | 1,423 | 990.75 | 839.44 | Upgrade
|
| Minority Interest in Earnings | -129.06 | -124.21 | -168.95 | -161.58 | -102.86 | -95.92 | Upgrade
|
| Net Income | 1,571 | 1,529 | 1,412 | 1,262 | 887.88 | 743.52 | Upgrade
|
| Net Income to Common | 1,571 | 1,529 | 1,412 | 1,262 | 887.88 | 743.52 | Upgrade
|
| Net Income Growth | 6.01% | 8.26% | 11.90% | 42.12% | 19.42% | 36.74% | Upgrade
|
| Shares Outstanding (Basic) | 1,209 | 1,213 | 1,207 | 1,202 | 1,193 | 1,157 | Upgrade
|
| Shares Outstanding (Diluted) | 1,237 | 1,233 | 1,207 | 1,211 | 1,203 | 1,157 | Upgrade
|
| Shares Change (YoY) | 1.53% | 2.15% | -0.37% | 0.70% | 4.01% | 0.31% | Upgrade
|
| EPS (Basic) | 1.30 | 1.26 | 1.17 | 1.05 | 0.74 | 0.64 | Upgrade
|
| EPS (Diluted) | 1.27 | 1.24 | 1.17 | 1.04 | 0.74 | 0.64 | Upgrade
|
| EPS Growth | 4.41% | 5.98% | 12.32% | 41.13% | 14.81% | 36.32% | Upgrade
|
| Free Cash Flow | 4,083 | 3,539 | 3,884 | 3,333 | 1,322 | 1,747 | Upgrade
|
| Free Cash Flow Per Share | 3.30 | 2.87 | 3.22 | 2.75 | 1.10 | 1.51 | Upgrade
|
| Dividend Per Share | 0.650 | 0.650 | 0.417 | 0.238 | 0.179 | 0.137 | Upgrade
|
| Dividend Growth | 55.99% | 55.99% | 75.01% | 33.31% | 29.98% | - | Upgrade
|
| Gross Margin | 39.87% | 39.77% | 37.89% | 39.25% | 40.08% | 37.74% | Upgrade
|
| Operating Margin | 9.44% | 9.24% | 8.91% | 9.69% | 8.99% | 9.06% | Upgrade
|
| Profit Margin | 6.52% | 6.35% | 6.25% | 6.35% | 5.79% | 5.66% | Upgrade
|
| Free Cash Flow Margin | 16.94% | 14.71% | 17.19% | 16.76% | 8.63% | 13.29% | Upgrade
|
| EBITDA | 2,532 | 2,473 | 2,231 | 2,115 | 1,521 | 1,303 | Upgrade
|
| EBITDA Margin | 10.51% | 10.28% | 9.88% | 10.63% | 9.93% | 9.91% | Upgrade
|
| D&A For EBITDA | 257.08 | 249.36 | 218.51 | 186.98 | 143.94 | 111.4 | Upgrade
|
| EBIT | 2,275 | 2,224 | 2,012 | 1,928 | 1,377 | 1,191 | Upgrade
|
| EBIT Margin | 9.44% | 9.24% | 8.91% | 9.69% | 8.99% | 9.06% | Upgrade
|
| Effective Tax Rate | 23.99% | 24.27% | 22.41% | 24.19% | 25.95% | 25.54% | Upgrade
|
| Revenue as Reported | 24,100 | 24,062 | 22,588 | 19,886 | 15,326 | 13,145 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.